Successful pregnancies following fertility-preserving treatment for ovarian carcinoma

被引:4
作者
Eitan, R
Chi, DS
机构
[1] Mem Sloan Kettering Canc Ctr, Gynecol Serv, Dept Surg, New York, NY 10021 USA
[2] Shaare Zedek Med Ctr, Jerusalem, Israel
来源
NATURE CLINICAL PRACTICE ONCOLOGY | 2005年 / 2卷 / 12期
关键词
cancer antigen 125; chemotherapy; epithelial ovarian carcinoma; pregnancy; surgery;
D O I
10.1038/ncponc0356
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: A 30-year-old woman underwent a routine sonogram at 6 weeks of gestation during her first pregnancy and was found to have a 6 cm complex right-ovarian mass, thought to be a dermoid cyst. The pregnancy progressed to term and the patient went on to have a normal vaginal delivery. At 3 months postpartum, she underwent a laparoscopic ovarian cystectomy. Preoperative serum cancer antigen 125 was within the normal range at 23.6 U/ml. Investigations: Pelvic ultrasound, evaluation of serum cancer antigen 125, abdominal and pelvic CT scans. Diagnosis: Stage IA clear-cell epithelial carcinoma of the right ovary. Management: Laparoscopic ovarian cystectomy, dilation and curettage, laparotomy, right salpingo-oophorectomy, infracolic omentectomy, peritoneal biopsy, peritoneal washing, appendectomy, bilateral pelvic and para-aortic lymphadenectomy, adjuvant chemotherapy with paclitaxel and carboplatin.
引用
收藏
页码:647 / 651
页数:5
相关论文
共 12 条
[1]
[Anonymous], 1998, Armed Forces Institute of Pathology
[2]
Boyd J, 1998, ONCOLOGY-NY, V12, P399
[3]
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers [J].
Chi, DS ;
Abu-Rustum, NR ;
Sonoda, Y ;
Ivy, J ;
Rhee, E ;
Moore, K ;
Levine, DA ;
Barakat, RR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (05) :1614-1619
[4]
Colombo N, 2003, J NATL CANCER I, V95, P125
[5]
Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[6]
Ries L.A., 2002, SEER CANC STAT REV 1
[7]
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy [J].
Schilder, JM ;
Thompson, AM ;
DePriest, PD ;
Ueland, FR ;
Cibull, ML ;
Kryscio, RJ ;
Modesitt, SC ;
Lu, KH ;
Geisler, JP ;
Higgins, RV ;
Magtibay, PM ;
Cohn, DE ;
Powell, MA ;
Chu, C ;
Stehman, FB ;
van Nagell, J .
GYNECOLOGIC ONCOLOGY, 2002, 87 (01) :1-7
[8]
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews [J].
Struewing, JP ;
Hartge, P ;
Wacholder, S ;
Baker, SM ;
Berlin, M ;
McAdams, M ;
Timmerman, MM ;
Brody, LC ;
Tucker, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20) :1401-1408
[9]
Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105
[10]
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial [J].
Trimbos, JB ;
Vergote, I ;
Bolis, G ;
Vermorken, JB ;
Mangioni, C ;
Madronal, C ;
Franchi, M ;
Tateo, S ;
Zanetta, G ;
Scarfone, G ;
Giurgea, L ;
Timmers, P ;
Coens, C ;
Pecorelli, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (02) :113-125